The assessment and enhancement of skin flap viability

Microcirculatory hemodynamics of the rat cremaster muscle flap in reduced blood flow states

Recent studies revealed that muscle and musculocutaneous flaps have the lowest peripheral resistance and best flap survival. The critical values of flow rates responsible for this survival have not been established. The authors evaluated the effect of prolonged arterial flow reduction on flow hemodynamics and muscle flap survival, independent of neovascularization using the rat cremaster muscle island flap model for microcirculatory studies. Muscle flaps were implanted into a transparent Plexiglas chamber to allow prolonged observation of the microcirculation. Twenty-six male Sprague-Dawley rats were studied in three experimental groups. In group I (control; no occlusion), after flap isolation, the cremaster muscle was implanted into the tissue chamber and microcirculatory measurements were performed from day 0 to day 3. In group II, after flap isolation, flow in the main feeding artery (the iliac) was reduced with a silk suture loop between 47% and 62%. In group III, arterial flow was reduced between 63% and 80%. Vessel diameters, red blood cell velocities, number of perfused capillaries, and number of rolling, sticking, and transmigrating leukocytes were reduced daily for each rat. Immediately after flow reduction, mean arteriolar (A1) diameters were significantly smaller in group II (25%) and group III (29%) compared with the controls (p<0.05). This reduction was confirmed by a drop in red blood cell velocities of 37% and 58% in groups II and III respectively (p<0.05). At day 1, more than 60% of group III flaps had no arterial flow, whereas normal flow was observed in control flaps for as long as 3 days. In addition, the number of perfused capillaries dropped significantly (by 42%) in group II flaps after 3 days (p<0.05). The authors conclude that continuous arterial blood flow reduction exceeding 60% of the normal volume, independent of angiogenesis, is incompatible with flap viability in the rat cremaster muscle model.

Relationship between skin fluorescence and blood flow in normal and in chronically ischemic subjects dosed with fluorescein

To elucidate parameters diagnostic of chronic ischemia, the fluorescence of skin on the foot, leg, arm, and forehead of six chronically ischemic patients and six normal subjects injected with fluorescein was measured serially using a surface-measurement fluorometer (dermofluorometer). Simultaneously collected plasma samples were assayed spectrofluorometrically for unmetabolized fluorescein. The time courses of plasma fluorescein content and dermofluorometer readings were jointly analyzed by combining a standard pharmacokinetic model, a model predicting skin site from plasma concentrations of fluorescein, and a model predicting the dermofluorometer response to those skin concentrations. Fluorescein plasma clearance (0.22 +/- 0.06 versus 0.46 +/- 0.20 L/h/kg) in ischemic patients was only half, and half-life was double (2.4 +/- 1.0 versus 1.3 +/- 0.3 h) those in normal subjects, with volume of distribution (Vdss = 0.46 L/kg) being similar. Despite the ischemia diagnosis for all patients involving claudication of the lower extremities, patients could be distinguished statistically from normal subjects on the basis of fluorescence readings taken on the arm, but not those using the foot or leg. The rate constant describing flux of fluorescein from the arm skin site in patients was only half that in normal subjects, and the peak reading on the arm occurred at 42 +/- 14 min after fluorescein injection in patients, but at only 15 +/- 6 min in normal subjects. Lack of discrimination between subject groups via leg and foot readings may be due to several physiologic and/or experimental factors, including the need to take skin surface readings much earlier than previously recognized.(ABSTRACT TRUNCATED AT 250 WORDS)

Fiberoptic fluorometer for skin flap assessment

The fiberoptic fluorometer permits quantitative measurement of fluorescence after intravenous administration of fluorescein. Accurate assessment of tissue fluorescence can be made at any time after the injection, and both uptake and elimination of fluorescein can be followed. The instrument provides instantaneous digital readout of the fluorescence measured in dye fluorescence (DF) units and an index predictive of viability called the dye fluorescence index (DFI). The unit is portable, can be sterilized for operating room use, and can be operated by paramedical personnel with ease. We have used the instrument extensively in clinical and laboratory investigations, where it has been highly reliable in predicting survival and necrosis of a wide variety of flaps. Little or no operating time is added, and serial, low-dose fluorescein injections may be used to monitor a flap in the recovery room or at the bedside in the early postoperative period.

Fluorometric assessment of skin flap viability in the rat: effect of radiation therapy

The fluorescein test is widely used to assess perfusion in skin flaps but tends to underestimate skin viability when visual inspection under ultraviolet light is employed. Fiberoptic dermofluorometry, which has recently been introduced, more accurately assesses fluorescein distribution in skin flaps than does visual inspection. Viability of the back flap in rats receiving ionizing radiation was evaluated by dermofluorometry. This technique was highly accurate in predicting viability and has great applicability for studying blood flow in irradiated tissues.